Form 8-K CODEXIS, INC. For: Aug 13

Go back to Form 8-K CODEXIS, INC. For: Aug 13

Stifel on Codexis, Inc. (CDXS): 'Key Milestones On the Horizon in 2H25'

August 14, 2025 10:35 AM EDT

Stifel analyst Daniel Arias reiterated a Buy rating and $5.00 price target on Codexis, Inc. (NASDAQ: CDXS).

The analyst comments "CDXS beat consensus on revs and provided a briefing on the encouraging status of the Pharma Biocatalysis business and the ECO Synthesis... More